Showing results (191-200 of 345) with videos related to
Sort By:
Pageof 35
Immunology Today|June 1, 1993
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantationT E Starzl, A J Demetris, N Murase, et al.Transplantation|August 29, 1998
Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrowM Terakura, N Murase, A J Demetris, et al.Transplantation|April 1, 1988
Influence of the hepatic drug-metabolizing enzyme-inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted ratsJ I Duncan, S D Heys, A W Thomson, et al.Agents and Actions|October 1, 1985
Immunosuppressive activity and toxicity of cyclosporin A in rats pretreated with high dose cyclophosphamideP A Brown, A W Thomson, P H Whiting, et al.Scandinavian Journal of Immunology|August 1, 1986
Inhibition of drug-induced eosinophilia by cyclosporin AA W Thomson, J I Milton, R D Aldridge, et al.Cytobios|January 1, 1986
A sequential study of hepatic structural damage following the intravenous injection of Corynebacterium parvumP W Johnston, J G Simpson, A W Thomson, et al.Transplantation|October 1, 1986
A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley ratsJ I Duncan, A W Thomson, J G Simpson, et al.Clinical Nephrology|January 1, 1986
Cyclosporine-induced renal structural damage: influence of dosage, strain, age and sex with reference to the rat and guinea pigJ I Duncan, A W Thomson, R D Aldridge, et al.The British Journal of Dermatology|November 1, 1990
Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activityJ I Duncan, S N Payne, A J Winfield, et al.Immunopharmacology|July 1, 1990
Alleviation of experimental cyclosporin A toxicity by substitution of fish muscle oil as drug vehicleI B Craighead, S D Heys, L M Smart, et al.Pageof 35